← Back to Clinical Trials
Recruiting NCT07117656

NCT07117656 Project Vuselela Feasibility

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07117656
Status Recruiting
Phase —
Sponsor Arizona State University
Condition HIV
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-07-13
Primary Completion 2027-08-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
All Conditions
Interventions
Project Vuselela

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-07-13 with a primary completion date of 2027-08-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To develop an intervention that engages family members in supporting HIV and opioid substitution therapy treatment for those who inject drugs in South Africa, and then conduct a pilot study to understand feasibility and preliminary impact on outcomes.

Eligibility Criteria

Inclusion Criteria: Aim 2 PLHWID Inclusion Criteria 1. Any sex or gender 2. \>18 years of age 3. HIV-positive as per medical record 4. Self-reported injection drug use behavior 5. Have not participated in the current ART-OST program 6. Initiating ART or OST 7. Identifies a potential family member who can provide support 8. Live in Johannesburg Family Member Inclusion Criteria 1. 18 years of age or older 2. Confirms family member (parent, sibling, partner, aunt, uncle, grandparent, cousin) 3. Knowledge of the drug using behavior by the PLWHID, but knowledge of their HIV status is not required. 4. No recent history of self-reported drug-using behavior (\< 5 years) Exclusion Criteria: PLHWID Exclusion Criteria 1. Under 18 years of age 2. HIV-negative as per medical record 3. Notself-reported injection drug use behavior 4. Has participated in the current ART-OST program 5. Taking ART or OST 6. Cannot identify a potential family member who can provide support 7. Does not live in Johannesburg Family Member Exclusion Criteria 1. Under 18 years of age 2. Not a family member 3. Does not know about drug using behavior by the PLWHID 4. Recent history of self-reported drug-using behavior (\< 5 years)

Contact & Investigator

Central Contact

Joseph A Daniels, PhD

✉ Joseph.A.Daniels@asu.edu

📞 206 459 5777

Frequently Asked Questions

Who can join the NCT07117656 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07117656 currently recruiting?

Yes, NCT07117656 is actively recruiting participants. Contact the research team at Joseph.A.Daniels@asu.edu for enrollment information.

Where is the NCT07117656 trial being conducted?

This trial is being conducted at Johannesburg, South Africa.

Who is sponsoring the NCT07117656 clinical trial?

NCT07117656 is sponsored by Arizona State University. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology